Skip to content

Veracyte VCYT Common Stock Shares Issued

Common Stock Shares Issued at other companies

Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's common stock shares issued?
Veracyte (VCYT) reported common stock shares issued of 79.8M in Q1 2026.
How has Veracyte's common stock shares issued changed year-over-year?
Veracyte's common stock shares issued increased by 1.9% year-over-year, from 78.3M to 79.8M.
What is the long-term trend for Veracyte's common stock shares issued?
Over 5 years (2020 to 2025), Veracyte's common stock shares issued has grown at a 6.4% compound annual growth rate (CAGR), from 58.2M to 79.4M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.